510(k) Report

510(k) · Cleared

Cleared

Endovascular Stent Planning Software

K143079510(k) TraditionalCleared Dec 4, 201438-day reviewClass II21 CFR 892.2050

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Vital Images, Inc. · LLZ System, Image Processing, Radiological

Cleared on Dec 4, 2014 as substantially equivalent to K091498 (Vital Images, Inc., 2009) after a 38-day review. Its family tree reaches back 11 generations to 1991.

Decided
Dec 4, 2014
Review
38 days
Class
Class II
Product code
LLZ
Recalls
None
Predicates
1

Its longest line of descent runs back 11 generations to K913770 (1991). 47 ancestors in all, the oldest K871859 (1987). No later device cites it as a predicate yet.

  1. Root · 11 generations backK913770 Advantage V.S. CT/MR Rad Diagnostic WorkstationGeneral Electric Co. · 1991
  2. 7 generations between
  3. 3 generations backK061624 Vitrea, Version 3.9Vital Images, Inc. · 2006 · Recalled
  4. 2 generations backK071331 Vitrea Version 4.0Vital Images, Inc. · 2007 · Recalled
  5. 1 generation backK091498 Vitrea Endovascular Stent Planning SoftwareVital Images, Inc. · 2009 · Recalled
  6. This deviceK143079 Endovascular Stent Planning SoftwareVital Images, Inc. · 2014
Show all 11 generations
  1. Root · 11 generations backK913770 Advantage V.S. CT/MR Rad Diagnostic WorkstationGeneral Electric Co. · 1991
  2. 10 generations backK960613 GE Advantage Windows Review WorkstationGE Medical Systems · 1996
  3. 9 generations backK020483 Advantage Workstation 4.1GE Medical Systems · 2002 · Recalled
  4. 8 generations backK023003 Imagechecker-CT WorkstationR2 Technology, Inc. · 2002
  5. 7 generations backK032748 VITREA2, Version 3.4 Medical Image Processing SoftwareVital Images, Inc. · 2003 · Recalled
  6. 6 generations backK040305 VITREA2 Version 3.5Vital Images, Inc. · 2004
  7. 5 generations backK043333 VITREA2, Version 3.7 Medical Image Processing SystemVital Images, Inc. · 2004 · Recalled
  8. 4 generations backK052632 VITREA2 Version 3.8 Medical Image Processing SoftwareVital Images, Inc. · 2005 · Recalled
  9. 3 generations backK061624 Vitrea, Version 3.9Vital Images, Inc. · 2006 · Recalled
  10. 2 generations backK071331 Vitrea Version 4.0Vital Images, Inc. · 2007 · Recalled
  11. 1 generation backK091498 Vitrea Endovascular Stent Planning SoftwareVital Images, Inc. · 2009 · Recalled
  12. This deviceK143079 Endovascular Stent Planning SoftwareVital Images, Inc. · 2014
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−11K913770Advantage V.S. CT/MR Rad Diagnostic WorkstationGeneral Electric Co.1991—
−10K960613GE Advantage Windows Review WorkstationGE Medical Systems1996—
−9K020483Advantage Workstation 4.1GE Medical Systems20022
−8K023003Imagechecker-CT WorkstationR2 Technology, Inc.2002—
−7K032748VITREA2, Version 3.4 Medical Image Processing SoftwareVital Images, Inc.20032
−6K040305VITREA2 Version 3.5Vital Images, Inc.2004—
−5K043333VITREA2, Version 3.7 Medical Image Processing SystemVital Images, Inc.20041
−4K052632VITREA2 Version 3.8 Medical Image Processing SoftwareVital Images, Inc.20052
−3K061624Vitrea, Version 3.9Vital Images, Inc.20061
−2K071331Vitrea Version 4.0Vital Images, Inc.20071
−1K091498Vitrea Endovascular Stent Planning SoftwareVital Images, Inc.20091
0 (this device)K143079Endovascular Stent Planning SoftwareVital Images, Inc.2014—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198710
199320
199420
199520
199640
199730
199820
199930
200030
200140
200230
200320
200430
200510
200610
FIG. 1 — Lineage of K143079, 1991–2014Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LLZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LLZ device

  1. #1 K230955 syngo Application Softwarescore 21.5 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K091498Vitrea Endovascular Stent Planning Software
Summary page 4
…a Submission: notification submission for proposed software changes in the already 510(k) cleared Endovascular Stent Planning software (K091498). Submitter: Vital Images, Inc. 5850 Opus Parkway Suite 300…
Vital Images, Inc.20091

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 23 years and passes through 4 companies; a new generation was cleared every 11 months on median.
  • 10 of the 47 ancestors have a recall of any class.

How does its category compare?

All LLZ devices

LLZ System, Image Processing, Radiological: FDA decisions, review times, recalls and adverse event reports over 20 years. 2014, this device’s year, is highlighted.

FDA decisions per year · LLZ

58in 2025

2007: 762008: 942009: 702010: 512011: 1062012: 822013: 952014: 782015: 642016: 822017: 782018: 1042019: 742020: 812021: 832022: 652023: 872024: 622025: 582026 (partial year): 45
2007high 106 (2011) · low 51 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LLZ

173in 2025

2007: 36 days median2008: 52 days median2009: 62 days median2010: 98 days median2011: 79 days median2012: 87 days median2013: 84 days median2014: 89 days median2015: 90 days median2016: 90 days median2017: 107 days median2018: 105 days median2019: 107 days median2020: 115 days median2021: 116 days median2022: 137 days median2023: 157 days median2024: 131 days median2025: 173 days median2026 (partial year): 110 days median
2007high 173 (2025) · low 36 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LLZ

11in 2025

2007: 202008: 322009: 212010: 172011: 302012: 122013: 642014: 62015: 162016: 122017: 52018: 72019: 22020: 62021: 32022: 42023: 82024: 62025: 112026 (partial year): 14
2007high 64 (2013) · low 2 (2019)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LLZ

116in 2025

2007: 1522008: 1542009: 1452010: 1452011: 4542012: 2662013: 1,1302014: 15,6312015: 2112016: 2902017: 1042018: 722019: 882020: 822021: 702022: 282023: 262024: 422025: 116
2007high 15,631 (2014) · low 26 (2023)2025

MAUDE reports naming product code LLZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007763620152
2008945232154
2009706221145
2010519817145
20111067930454
2012828712266
20139584641,130
20147889615,631
2015649016211
2016829012290
2017781075104
2018104105772
201974107288
202081115682
202183116370
202265137428
202387157826
202462131642
20255817311116
20264511014—

What is it indicated for?

Vitrea® is a medical diagnostic system that allows the processing, review, analysis, communication and media interchange of multi-dimensional digital images acquired from a variety of imaging devices. Vitrea is not meant for primary image interpretation in mammography. Vitrea has the following additional indication: The Endovascular Stent Planning Software application is intended for use with CT (computed tomography) images to assist medical…

Read the full statement (126 words)

Vitrea® is a medical diagnostic system that allows the processing, review, analysis, communication and media interchange of multi-dimensional digital images acquired from a variety of imaging devices. Vitrea is not meant for primary image interpretation in mammography. Vitrea has the following additional indication:

The Endovascular Stent Planning Software application is intended for use with CT (computed tomography) images to assist medical professionals in the analysis, treatment and follow-up of aortic vascular disorders that may require a stent procedure. The software provides 3D segmentation of the aorta and initializes stent measurements based on a template provided by the stent manufacturers. The user can review the 2D and 3D images, verify and correct the results of the segmentation and initialization, and generate a report with the stent measurements.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K143079: Endovascular Stent Planning Software.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K143079

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026